DAVID CORRY to Prospective Studies
This is a "connection" page, showing publications DAVID CORRY has written about Prospective Studies.
Connection Strength
0.060
-
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. Nat Microbiol. 2026 Apr; 11(4):1100-1112.
Score: 0.028
-
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. EBioMedicine. 2022 Sep; 83:104208.
Score: 0.022
-
Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health. 2011 05; 8(5):1324-40.
Score: 0.010